• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theratechnologies Inc

+ Add to Watchlist

TQ8:GR

0.298 EUR 0.003 1.02%

As of 09:36:27 ET on 08/01/2014.

Snapshot for Theratechnologies Inc (TQ8)

Open: 0.298 Day's Range: 0.298 - 0.298 Volume: 0
Previous Close: 0.295 52wk Range: 0.109 - 0.342 1-Yr Rtn: +27.90%

Stock Chart for TQ8

No chart data available.
  • TQ8:GR 0.298
  • 1D
  • 1M
  • 1Y
0.295
Interactive TQ8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TQ8

Current P/E Ratio (ttm) -
Estimated P/E(11/2014) -
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (11/2014) -0.1300
Est. PEG Ratio -
Market Cap (M EUR) 18.18
Shares Outstanding (M) 61.01
30 Day Average Volume 123
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TQ8

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TQ8

Theratechnologies, Inc. is a specialty pharmaceutical company that discovers and develops therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. The Company's main product is being marketed in the United States for the reduction of excess abdominal fat n HIV-infected patients with lipodystrophy.

Luc TanguayPres/CEO/Investor RelationsLyne FortinChief Commercial Officer
Christian MarsolaisSenior VP:Scientific AffairsMarie-Noel ColussiVP:Finance
More Company Profile & Key Executives for TQ8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil